Furthermore, it has been demonstrated that the CDK1/Sox2 axis acts as an important axis in the control and maintenance of the stemness of lung cancer cells, and inhibiting CDK1 increases the sensitivity of lung cancer to chemotherapeutics [72]. Here, SOX2 is linked to lung carcinoma.